Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Pardo LM, Voigt AP, Alonzo TA, Wilson ER, Gerbing RB, Paine DJ, Dai F, Menssen AJ, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Wells DA, Brodersen LE, Loken MR.

Cytometry B Clin Cytom. 2019 Jul 11. doi: 10.1002/cyto.b.21829. [Epub ahead of print]

PMID:
31294507
2.

Decoupling of Genetic and Cultural Inheritance in a Wild Mammal.

Sheppard CE, Marshall HH, Inger R, Thompson FJ, Vitikainen EIK, Barker S, Nichols HJ, Wells DA, McDonald RA, Cant MA.

Curr Biol. 2018 Jun 4;28(11):1846-1850.e2. doi: 10.1016/j.cub.2018.05.001. Epub 2018 May 24.

3.

A high-quality pedigree and genetic markers both reveal inbreeding depression for quality but not survival in a cooperative mammal.

Wells DA, Cant MA, Nichols HJ, Hoffman JI.

Mol Ecol. 2018 May;27(9):2271-2288. doi: 10.1111/mec.14570. Epub 2018 Apr 29.

PMID:
29603504
4.

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.

Valent P, Orazi A, Steensma DP, Ebert BL, Haase D, Malcovati L, van de Loosdrecht AA, Haferlach T, Westers TM, Wells DA, Giagounidis A, Loken M, Orfao A, Lübbert M, Ganser A, Hofmann WK, Ogata K, Schanz J, Béné MC, Hoermann G, Sperr WR, Sotlar K, Bettelheim P, Stauder R, Pfeilstöcker M, Horny HP, Germing U, Greenberg P, Bennett JM.

Oncotarget. 2017 Jul 5;8(43):73483-73500. doi: 10.18632/oncotarget.19008. eCollection 2017 Sep 26.

5.

Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.

Voigt AP, Brodersen LE, Alonzo TA, Gerbing RB, Menssen AJ, Wilson ER, Kahwash S, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Wells DA, Loken MR.

Haematologica. 2017 Dec;102(12):2058-2068. doi: 10.3324/haematol.2017.169029. Epub 2017 Sep 7.

6.

Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

Burnworth B, Wang Z, Singleton TP, Bennington A, Fritschle W, Bennington R, Brodersen LE, Wells DA, Loken MR, Zehentner BK.

Leuk Res. 2016 Dec;51:41-48. doi: 10.1016/j.leukres.2016.10.008. Epub 2016 Oct 18.

PMID:
27890075
7.

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.

Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, Orfao A, Moshaver B, Brodersen LE, Loken MR, Wells DA, Subirá D, Cullen M, Te Marvelde JG, van der Velden VH, Preijers FW, Chu SC, Feuillard J, Guérin E, Psarra K, Porwit A, Saft L, Ireland R, Milne T, Béné MC, Witte BI, Della Porta MG, Kern W, van de Loosdrecht AA; IMDSFlow Working Group.

Haematologica. 2017 Feb;102(2):308-319. doi: 10.3324/haematol.2016.147835. Epub 2016 Oct 6.

8.

Consistent quantitative gene product expression: #3. Invariance with age.

Loken MR, Voigt AP, Eidenschink Brodersen L, Fritschle W, Menssen AJ, Wells DA.

Cytometry A. 2016 Nov;89(11):997-1000. doi: 10.1002/cyto.a.22997. Epub 2016 Oct 18.

9.

Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals.

Loken MR, Voigt AP, Eidenschink Brodersen L, Fritschle W, Menssen AJ, Meshinchi S, Wells DA.

Cytometry A. 2016 Nov;89(11):987-996. doi: 10.1002/cyto.a.22999. Epub 2016 Oct 18.

10.

Re: Lee H, et al. An unusual case of myeloperoxidase-positive acute megakaryoblastic leukemia. Ann Lab Med 2015;35:466-8.

Bennett JM, Wells DA.

Ann Lab Med. 2015 Sep;35(5):542-3. doi: 10.3343/alm.2015.35.5.542. No abstract available.

11.

Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.

Eidenschink Brodersen L, Menssen AJ, Wangen JR, Stephenson CF, de Baca ME, Zehentner BK, Wells DA, Loken MR.

Cytometry B Clin Cytom. 2015 Mar;88(2):125-35. doi: 10.1002/cyto.b.21199. Epub 2014 Dec 10.

12.

Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry work-up.

Eidenschink Brodersen L, Menssen AJ, Wangen JR, Stephenson CF, de Baca ME, Zehentner BK, Wells DA, Loken MR.

Cytometry B Clin Cytom. 2014 Oct 21. doi: 10.1002/cytob.21199. [Epub ahead of print]

13.

Detection of clonal evolution in hematopoietic malignancies by combining comparative genomic hybridization and single nucleotide polymorphism arrays.

Hartmann L, Stephenson CF, Verkamp SR, Johnson KR, Burnworth B, Hammock K, Brodersen LE, de Baca ME, Wells DA, Loken MR, Zehentner BK.

Clin Chem. 2014 Dec;60(12):1558-68. doi: 10.1373/clinchem.2014.227785. Epub 2014 Oct 15.

14.

Male brush-turkeys attempt sexual coercion in unusual circumstances.

Wells DA, Jones DN, Bulger D, Brown C.

Behav Processes. 2014 Jul;106:180-6. doi: 10.1016/j.beproc.2014.06.002. Epub 2014 Jun 13.

PMID:
24932897
15.

Prognostic significance of flow cytometric residual disease, dysregulated neutrophils/monocytes, and hematogones in adult acute myeloid leukemia in first remission.

Chu SC, Wang TF, Su YC, Kao RH, Wu YF, Li DK, Li SC, Li CC, Wells DA, Loken MR.

Int J Hematol. 2014 Mar;99(3):296-304. doi: 10.1007/s12185-014-1525-y. Epub 2014 Jan 31.

PMID:
24481944
16.

Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation.

Wangen JR, Eidenschink Brodersen L, Stolk TT, Wells DA, Loken MR.

Int J Lab Hematol. 2014 Apr;36(2):184-96. doi: 10.1111/ijlh.12151. Epub 2013 Oct 3.

PMID:
24118926
17.

Intraclonal heterogeneity in concomitant monoclonal lymphocyte and plasma cell populations: combining flow cytometric cell sorting with molecular monoclonality profiling.

Zehentner BK, de Baca ME, Wells DA, Loken MR.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):214-7. doi: 10.1016/j.clml.2013.02.004. Epub 2013 Mar 13.

PMID:
23490988
18.

Array-based karyotyping in plasma cell neoplasia after plasma cell enrichment increases detection of genomic aberrations.

Zehentner BK, Hartmann L, Johnson KR, Stephenson CF, Chapman DB, de Baca ME, Wells DA, Loken MR, Tirtorahardjo B, Gunn SR, Lim L.

Am J Clin Pathol. 2012 Oct;138(4):579-89.

PMID:
23010713
19.

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.

van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, Cazzola M, Chu SS, Cullen M, Cutler JA, Dräger AM, Feuillard J, Fenaux P, Font P, Germing U, Haase D, Hellström-Lindberg E, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Nikolova V, Ogata K, Oelschlaegel U, Orfao A, Ossenkoppele GJ, Porwit A, Platzbecker U, Preijers F, Psarra K, Richards SJ, Subirá D, Seymour JF, Tindell V, Vallespi T, Valent P, van der Velden VH, Wells DA, de Witte TM, Zettl F, Béné MC, Westers TM.

Leuk Lymphoma. 2013 Mar;54(3):472-5. doi: 10.3109/10428194.2012.718341. Epub 2012 Sep 14. Review.

PMID:
22916713
20.

Response to "Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome".

Wells DA, Loken MR.

Ann Hematol. 2012 Dec;91(12):1983. doi: 10.1007/s00277-012-1504-4. Epub 2012 Jun 16. No abstract available.

PMID:
22706670
21.

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.

Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Ogata K, Orfao A, Porwit A, Psarra K, Richards SJ, Subirá D, Tindell V, Vallespi T, Valent P, van der Velden VH, de Witte TM, Wells DA, Zettl F, Béné MC, van de Loosdrecht AA.

Leukemia. 2012 Jul;26(7):1730-41. doi: 10.1038/leu.2012.30. Epub 2012 Feb 6.

PMID:
22307178
22.

Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.

Hartmann L, Biggerstaff JS, Chapman DB, Scott JM, Johnson KR, Ghirardelli KM, Fritschle WK, Martinez DL, Bennington RK, de Baca ME, Wells DA, Loken MR, Zehentner BK.

Am J Clin Pathol. 2011 Nov;136(5):712-20. doi: 10.1309/AJCPF7NFLW8UAJEP.

PMID:
22031309
23.

Basal levels of CD34 positive cells in peripheral blood differ between individuals and are stable for 18 months.

Eidenschink L, DiZerega G, Rodgers K, Bartlett M, Wells DA, Loken MR.

Cytometry B Clin Cytom. 2012 Jan;82(1):18-25. doi: 10.1002/cyto.b.20611. Epub 2011 Aug 2.

24.

A minority of concurrent monoclonal lymphocytes and plasmacytic cells sharing light chains are genetically related in putative lymphoplasmacytic lymphoma.

Zehentner BK, Cutler JA, Fritschle WK, Bennington RK, Wentzel C, Smading SR, Jeffery EW, Wells DA, Loken MR.

Leuk Res. 2011 Dec;35(12):1597-604. doi: 10.1016/j.leukres.2011.06.012. Epub 2011 Jul 14.

PMID:
21752465
25.

Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias.

Cutler JA, Wells DA, van de Loosdrecht AA, de Baca ME, Kalnoski MH, Zehentner BK, Eidenschink L, Ghirardelli KM, Biggerstaff JS, Loken MR.

Cytometry B Clin Cytom. 2011 May;80(3):150-7. doi: 10.1002/cyto.b.20582. Epub 2010 Dec 23.

26.

Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.

Chu SC, Wang TF, Li CC, Kao RH, Li DK, Su YC, Wells DA, Loken MR.

Leuk Res. 2011 Jul;35(7):868-73. doi: 10.1016/j.leukres.2011.02.016. Epub 2011 Mar 12.

PMID:
21397943
27.

Minimal residual disease detected prior to hematopoietic cell transplantation.

Foster JH, Hawkins DS, Loken MR, Wells DA, Thomson B.

Pediatr Blood Cancer. 2011 Jul 15;57(1):163-5. doi: 10.1002/pbc.23079. Epub 2011 Mar 2.

PMID:
21370437
28.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

van de Loosdrecht AA, Alhan C, Béné MC, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, Te Marvelde JG, Mufti GJ, Ogata K, Orfao A, Ossenkoppele GJ, Porwit A, Preijers FW, Richards SJ, Schuurhuis GJ, Subirá D, Valent P, van der Velden VH, Vyas P, Westra AH, de Witte TM, Wells DA, Loken MR, Westers TM.

Haematologica. 2009 Aug;94(8):1124-34. doi: 10.3324/haematol.2009.005801. Epub 2009 Jun 22.

29.

Do you come to work with a respiratory tract infection?

Gudgeon P, Wells DA, Baerlocher MO, Detsky AS.

Occup Environ Med. 2009 Jun;66(6):424. doi: 10.1136/oem.2008.043927. No abstract available.

PMID:
19451145
30.

The role of flow cytometry in myelodysplastic syndromes.

Loken MR, Wells DA.

J Natl Compr Canc Netw. 2008 Oct;6(9):935-41.

PMID:
18926102
31.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome.

Scott BL, Wells DA, Loken MR, Myerson D, Leisenring WM, Deeg HJ.

Blood. 2008 Oct 1;112(7):2681-6. doi: 10.1182/blood-2008-05-153700. Epub 2008 Jul 7.

32.

Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.

Loken MR, Chu SC, Fritschle W, Kalnoski M, Wells DA.

Cytometry B Clin Cytom. 2009 Jan;76(1):27-36. doi: 10.1002/cyto.b.20429. Epub 2008 Jun 11.

33.

What is different about the market for health care?

Wells DA, Ross JS, Detsky AS.

JAMA. 2007 Dec 19;298(23):2785-7. doi: 10.1001/jama.298.23.2785. No abstract available.

PMID:
18165673
34.

On flow cytometry in myelodysplastic syndromes, with caveats.

Wells DA, Ogata K.

Leuk Res. 2008 Feb;32(2):209-10. Epub 2007 Sep 7. No abstract available.

PMID:
17825408
35.

Flow cytometry in myelodysplastic syndromes: report from a working conference.

Loken MR, van de Loosdrecht A, Ogata K, Orfao A, Wells DA.

Leuk Res. 2008 Jan;32(1):5-17. Epub 2007 Jun 18.

PMID:
17576013
36.

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.

Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA.

Leuk Res. 2007 Jun;31(6):727-36. Epub 2007 Jan 25. Review.

PMID:
17257673
37.

India: a pharmacist's medical mission.

Wells DA.

Am J Health Syst Pharm. 2006 Nov 1;63(21):2048, 2050. No abstract available.

PMID:
17057038
38.
39.

Minimal disease detection and confirmation in hematologic malignancies: combining cell sorting with clonality profiling.

Zehentner BK, Fritschle W, Stelzer T, Ghirardelli KM, Hunter K, Wentzel C, Bennington R, Hansen CL, Myerson D, Kalnoski M, Wells DA, Loken MR.

Clin Chem. 2006 Mar;52(3):430-7. Epub 2006 Jan 12.

40.

Positioning for acute respiratory distress in hospitalised infants and children.

Wells DA, Gillies D, Fitzgerald DA.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003645. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD003645.

PMID:
15846674
41.
42.

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ.

Blood. 2003 Jul 1;102(1):394-403. Epub 2003 Mar 20.

PMID:
12649150
43.

Thermal injury-induced increases of hepatocyte SOCS3 lead to decreases in STAT3.

Kong F, Guo X, Noel JG, Wells DA, Lovell GJ, Ogle CK.

Shock. 2002 Oct;18(4):374-9.

PMID:
12392283
44.

The ability of endotoxin-stimulated enterocytes to produce bactericidal factors.

Ogle CK, Noel JG, Guo X, Wells DA, Valente JF, Ogle JD, Alexander JW.

Crit Care Med. 2002 Feb;30(2):428-34.

PMID:
11889324
45.

Thermal injury increases the number of eosinophil progenitors in rat spleen and bone marrow.

Noel JG, Wells DA, Guo X, Kong F, Lovell GJ, Ogle CK.

Inflammation. 2001 Oct;25(5):339-49.

PMID:
11820461
46.

The effect of burn injury on suppressors of cytokine signalling.

Ogle CK, Kong F, Guo X, Wells DA, Aosasa S, Noel G, Horseman N.

Shock. 2000 Sep;14(3):392-8; discussion 398-9.

PMID:
11028562
47.
48.

Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias.

Wells DA, Hall MC, Shulman HM, Loken MR.

Leukemia. 1998 Dec;12(12):2015-23.

49.

Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation.

Wells DA, Sale GE, Shulman HM, Myerson D, Bryant EM, Gooley T, Loken MR.

Am J Clin Pathol. 1998 Jul;110(1):84-94.

PMID:
9661926
50.

Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.

Sievers EL, Lange BJ, Buckley JD, Smith FO, Wells DA, Daigneault-Creech CA, Shults KE, Bernstein ID, Loken MR.

J Natl Cancer Inst. 1996 Oct 16;88(20):1483-8.

PMID:
8841024

Supplemental Content

Loading ...
Support Center